Australia markets open in 1 hour 44 minutes

Silk Road Medical, Inc (SILK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
20.28+1.38 (+7.30%)
At close: 04:00PM EDT
20.01 -0.27 (-1.33%)
After hours: 06:38PM EDT

Silk Road Medical, Inc

1213 Innsbruck Drive
Sunnyvale, CA 94089
United States
408 720 9002
https://silkroadmed.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees474

Key executives

NameTitlePayExercisedYear born
Mr. Charles S. McKhannCEO & Director300.77kN/A1969
Mr. Lucas W. BuchananCFO & COO836.87k4.05M1978
Mr. Kevin M. KlemzEVP, Chief Legal Officer & Secretary665.34kN/A1961
Mr. Andrew S. DavisChief Commercial Officer1.2M1.45M1969
Mr. Richard M. RuedyExecutive Vice President of Clinical, Regulatory Affairs & Quality Assurance476.27kN/A1967
Ms. Mhairi L. JonesChief Accounting Officer & VP of FinanceN/AN/A1971
Ms. Tammy LeitsingerCompliance Officer & VP of Medical AffairsN/AN/AN/A
Mr. Jorge O'HaraVice President of Marketing, Business Development & StrategyN/AN/AN/A
Ms. Alison HighlanderVice President of Human ResourcesN/AN/AN/A
Dr. Sumaira MacDonald M.D., Ph.D.Executive Medical DirectorN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Corporate governance

Silk Road Medical, Inc’s ISS governance QualityScore as of 1 May 2024 is 9. The pillar scores are Audit: 8; Board: 5; Shareholder rights: 7; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.